Full closed loop open-source algorithm performance comparison in pigs with diabetes

被引:13
作者
Lal, Rayhan A. [1 ,2 ,3 ]
Maikawa, Caitlin L. [4 ]
Lewis, Dana [5 ]
Baker, Sam W. [6 ]
Smith, Anton A. A. [7 ]
Roth, Gillie A. [4 ]
Gale, Emily C. [8 ]
Stapleton, Lyndsay M. [4 ]
Mann, Joseph L. [7 ]
Yu, Anthony C. [7 ]
Correa, Santiago [7 ]
Grosskopf, Abigail K. [9 ]
Liong, Celine S. [4 ]
Meis, Catherine M. [7 ]
Chan, Doreen [10 ]
Garner, Joseph P. [6 ,11 ]
Maahs, David M. [2 ,3 ]
Buckingham, Bruce A. [2 ,3 ]
Appel, Eric A. [2 ,3 ,4 ,7 ]
机构
[1] Stanford Univ, Dept Med, Div Endocrinol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat, Div Endocrinol, Stanford, CA 94305 USA
[3] Stanford Univ, Stanford Diabet Res Ctr, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
[5] OpenAPS, Seattle, WA USA
[6] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA
[7] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA
[8] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA
[9] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA
[10] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
[11] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
基金
美国国家科学基金会; 加拿大自然科学与工程研究理事会;
关键词
automated insulin delivery; diabetes; open‐ source closed loop; ARTIFICIAL PANCREAS; GLYCEMIC CONTROL; GLUCOSE CONTROL; ADULTS;
D O I
10.1002/ctm2.387
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Understanding how automated insulin delivery (AID) algorithm features impact glucose control under full closed loop delivery represents a critical step toward reducing patient burden by eliminating the need for carbohydrate entries at mealtimes. Here, we use a pig model of diabetes to compare AndroidAPS and Loop open-source AID systems without meal announcements. Overall time-in-range (70-180 mg/dl) for AndroidAPS was 58% +/- 5%, while time-in-range for Loop was 35% +/- 5%. The effect of the algorithms on time-in-range differed between meals and overnight. During the overnight monitoring period, pigs had an average time-in-range of 90% +/- 7% when on AndroidAPS compared to 22% +/- 8% on Loop. Time-in-hypoglycemia also differed significantly during the lunch meal, whereby pigs running AndroidAPS spent an average of 1.4% (+0.4/-0.8)% in hypoglycemia compared to 10% (+3/-6)% for those using Loop. As algorithm design for closed loop systems continues to develop, the strategies employed in the OpenAPS algorithm (known as oref1) as implemented in AndroidAPS for unannounced meals may result in a better overall control for full closed loop systems.
引用
收藏
页数:14
相关论文
共 35 条
[1]  
AndroidAPS Community, 2020, ANDROIDAPS DOCUMENTA
[2]   Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range [J].
Battelino, Tadej ;
Danne, Thomas ;
Bergenstal, Richard M. ;
Amiel, Stephanie A. ;
Beck, Roy ;
Biester, Torben ;
Bosi, Emanuele ;
Buckingham, Bruce A. ;
Cefalu, William T. ;
Close, Kelly L. ;
Cobelli, Claudio ;
Dassau, Eyal ;
DeVries, J. Hans ;
Donaghue, Kim C. ;
Dovc, Klemen ;
Doyle, Francis J. ;
Garg, Satish ;
Grunberger, George ;
Heller, Simon ;
Heinemann, Lutz ;
Hirsch, Irl B. ;
Hovorka, Roman ;
Jia, Weiping ;
Kordonouri, Olga ;
Kovatchev, Boris ;
Kowalski, Aaron ;
Laffel, Lori ;
Levine, Brian ;
Mayorov, Alexander ;
Mathieu, Chantal ;
Murphy, Helen R. ;
Nimri, Revital ;
Norgaard, Kirsten ;
Parkin, Christopher G. ;
Renard, Eric ;
Rodbard, David ;
Saboo, Banshi ;
Schatz, Desmond ;
Stoner, Keaton ;
Urakami, Tatsuiko ;
Weinzimer, Stuart A. ;
Phillip, Moshe .
DIABETES CARE, 2019, 42 (08) :1593-1603
[3]   Closed loop insulin delivery in diabetes [J].
Battelino, Tadej ;
Omladic, Jasna Suput ;
Phillip, Moshe .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 29 (03) :315-325
[4]   Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial [J].
Blauw, Helga ;
Onvlee, A. Joannet ;
Klaassen, Michel ;
van Bon, Arianne C. ;
DeVries, J. Hans .
DIABETES CARE, 2021, 44 (03) :836-838
[5]   Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective? [J].
Boughton, C. K. ;
Hovorka, R. .
DIABETIC MEDICINE, 2019, 36 (03) :279-286
[6]   Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes [J].
Braune, Katarina ;
O'Donnell, Shane ;
Cleal, Bryan ;
Lewis, Dana ;
Tappe, Adrian ;
Willaing, Ingrid ;
Hauck, Bastian ;
Raile, Klemens .
JMIR MHEALTH AND UHEALTH, 2019, 7 (07)
[7]   CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes [J].
Burnside, M. ;
Lewis, D. ;
Crocket, H. ;
Wilson, R. ;
Williman, J. ;
Jefferies, C. ;
Paul, R. ;
Wheeler, B. J. ;
de Bock, Martin .
JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (02) :1615-1629
[9]   Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial [J].
Dovc, Klemen ;
Piona, Claudia ;
Mutlu, Guel Yesiltepe ;
Bratina, Natasa ;
Bizjan, Barbara Jenko ;
Lepej, Dusanka ;
Nimri, Revital ;
Atlas, Eran ;
Muller, Ido ;
Kordonouri, Olga ;
Biester, Torben ;
Danne, Thomas ;
Phillip, Moshe ;
Battelino, Tadej .
DIABETES CARE, 2020, 43 (01) :29-36
[10]  
Eli Lilly Canada Inc , 2017, HUMALOG INSULIN LISP